Wide Awake Local Anesthesia No Tourniquet

Trigger Finger Disorder Clinical Trial

— WALANT  

Official title:

Wide Awake Local Anesthesia No Tourniquet

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03663608
• Other study ID #: 35RC17-3065_WALANT
• Status: Completed
• Start date: November 20, 2017
• Est. completion date: November 12, 2018

Study information

• Verified date: April 2022
• Source: Rennes University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective is to assess patient's satisfaction regarding pure local anaesthesia and without use of a tourniquet (WALANT Technique) for trigger finger release surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 57
• Est. completion date: November 12, 2018
• Est. primary completion date: November 12, 2018
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients of age
• Isolated Trigger finger, diagnosis confirmed by sonography and with indication of surgical release
• Patients protected by health insurance
• Patients who have received proper information on the current research proctol, and did not refuse to enter the study

Exclusion Criteria:

• Hand vascular disorders ( History of finger replantation surgery, clinical signs of poor hand vascularization
• Hypersensitivy to Xylocain or Adrenalin or one of it's components
• Other surgical act planned to be performed during the same anaesthesia
• Pregnant or Breastfeeding women
• Patients of age and under the protection of a conservator, patients deprived of liberty

Related Conditions & MeSH terms

• Trigger Finger Disorder

Intervention

Procedure:
• WALANT Technique
pure local anaesthesia and without use of a tourniquet (WALANT Technique) for trigger finger release surger

Locations

Country	Name	City	State
France	Centre Hospitalier Privé de Plérin	Plérin
France	CHU de Rennes	Rennes

Sponsors (1)

Lead Sponsor	Collaborator
Rennes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient satisfaction	Patient's agreement to use WALANT for possible surgeries to come and Patient's agreement to refer WALANT to his close relatives if they were to undergo surgery	one day after surgery